Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2015

View Archived Issues

NO-donating bimatoprost shows preclinical efficacy reducing IOP

FDA designates Cidara's CD-101 IV as QIDP

Lilly and BioNTech form cancer immunotherapy collaboration

NAPs show promising sequence-independent antiviral activity

Retrophin introduces compounds for the treatment of neurodegeneration

Roche patents CYP11B2 inhibitors

Astellas to access Cyclenium's macrocycle drug discovery technologies

Roivant Sciences licenses nelotanserin from Arena Pharmaceuticals

Sumitomo Dainippon Pharma profiles progress of fourth quarter of fiscal 2014

Celprogen reveals pancreatic stem cell stimulator STEMC-7007

Data on REGN-844 for dry eye disease reported

PIM-447 shows potential for the treatment of MM

Merck & Co. discloses ROM-K channel blockers

Michael J. Fox Foundation acquires research tools from Imago

Dana-Farber, Syros Pharmaceuticals and Paraza Pharma jointly patent CDK7 inhibitors

Evofosfamide receives FDA fast track designation for pancreatic cancer

Shionogi prepares and tests ACC2 inhibitors

Astellas Pharma discloses GABA(B) positive allosteric modulators

Intravitreal CD34+ autologous bone marrow-derived cells safe in dry AMD patients

MorphoSys completes acquisition of Lanthio Pharma

FDA advisory committee recommends approval of Orkambi for cystic fibrosis

Preliminary phase I results of Ebola prime-boost vaccine regimen of MVA-BN Filo and AdVac

Takeda terminates phase III trial of alisertib in peripheral T-cell lymphoma

Fibrocell's FCX-007 receives rare pediatric disease designation from the FDA

FDA awards orphan drug designation to SemiAlloGen's approach to targeting glioblastoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...